{"id":"https://openalex.org/W1964072039","doi":"https://doi.org/10.2174/092986706777442011","title":"Selective \u03b17 Nicotinic Acetylcholine Receptor Ligands","display_name":"Selective \u03b17 Nicotinic Acetylcholine Receptor Ligands","alternate_titles":[],"publication_year":2006,"publication_date":"2006-05-30","ids":{"openalex":"https://openalex.org/W1964072039","doi":"https://doi.org/10.2174/092986706777442011","mag":"1964072039","pmid":"https://pubmed.ncbi.nlm.nih.gov/16787204"},"language":"en","primary_location":{"id":"doi:10.2174/092986706777442011","doi":"https://doi.org/10.2174/092986706777442011","is_oa":false,"landing_page_url":"https://doi.org/10.2174/092986706777442011","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1964072039"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109033892","display_name":"Anatoly A. Mazurov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anatoly Mazurov","raw_affiliation_strings":["Targacept, Inc., Winston-Salem, North Carolina 27101, USA. Anatoly.Mazurov@targacept.com","Targacept, Inc., Winston-Salem, North Carolina 27101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Targacept, Inc., Winston-Salem, North Carolina 27101, USA. Anatoly.Mazurov@targacept.com","institution_ids":[]},{"raw_affiliation_string":"Targacept, Inc., Winston-Salem, North Carolina 27101, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050134269","display_name":"Terry A. Hauser","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terry Hauser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110491767","display_name":"Craig H. Miller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Craig Miller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.3253,"has_fulltext":false,"cited_by_count":127,"citation_normalized_percentile":{"value":0.95891279,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"13","issue":"13","first_page":"1567","last_page":"1584"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha7-nicotinic-acetylcholine-receptor","display_name":"alpha7 nicotinic acetylcholine receptor","score":0.9940000176429749},{"id":"https://openalex.org/keywords/selective-ligands","display_name":"selective ligands","score":0.5600000023841858},{"id":"https://openalex.org/keywords/receptor-agonists","display_name":"receptor agonists","score":0.6370000243186951},{"id":"https://openalex.org/keywords/allosteric-modulators","display_name":"allosteric modulators","score":0.906000018119812},{"id":"https://openalex.org/keywords/receptor-antagonists","display_name":"receptor antagonists","score":0.781000018119812},{"id":"https://openalex.org/keywords/receptor-desensitization","display_name":"receptor desensitization","score":0.8429999947547913},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8840000033378601},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cognitive-disorders","display_name":"cognitive disorders","score":0.8939999938011169},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.8460000157356262},{"id":"https://openalex.org/keywords/ligand-gated-ion-channels","display_name":"ligand-gated ion channels","score":0.7940000295639038},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.8284851312637329},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.7838395237922668},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5998585224151611},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5368751883506775},{"id":"https://openalex.org/C2779570518","wikidata":"https://www.wikidata.org/wiki/Q412256","display_name":"Nicotinic acetylcholine receptor","level":4,"score":0.5110660791397095},{"id":"https://openalex.org/C80161118","wikidata":"https://www.wikidata.org/wiki/Q408520","display_name":"Acetylcholine receptor","level":3,"score":0.4875344932079315},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47405192255973816},{"id":"https://openalex.org/C82617044","wikidata":"https://www.wikidata.org/wiki/Q418536","display_name":"Ligand-gated ion channel","level":4,"score":0.4430459439754486},{"id":"https://openalex.org/C2776038425","wikidata":"https://www.wikidata.org/wiki/Q2649417","display_name":"Allosteric modulator","level":4,"score":0.4356450140476227},{"id":"https://openalex.org/C50254741","wikidata":"https://www.wikidata.org/wiki/Q62536","display_name":"Ion channel","level":3,"score":0.42446744441986084},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34799811244010925},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23752254247665405},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14732933044433594}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001842","descriptor_name":"Bone and Bones","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001842","descriptor_name":"Bone and Bones","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001842","descriptor_name":"Bone and Bones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015663","descriptor_name":"Osteoporosis, Postmenopausal","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015663","descriptor_name":"Osteoporosis, Postmenopausal","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D064569","descriptor_name":"alpha7 Nicotinic Acetylcholine Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/092986706777442011","doi":"https://doi.org/10.2174/092986706777442011","is_oa":false,"landing_page_url":"https://doi.org/10.2174/092986706777442011","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:16787204","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16787204","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2050406169","https://openalex.org/W2767064823","https://openalex.org/W2060273749","https://openalex.org/W79013629","https://openalex.org/W2057552760","https://openalex.org/W2252938599","https://openalex.org/W2320327264","https://openalex.org/W1565289973","https://openalex.org/W2059465662","https://openalex.org/W2767310948"],"abstract_inverted_index":{"Neuronal":[0],"nicotinic":[1,57],"acetylcholine":[2],"receptors":[3],"(nAChRs)":[4],"are":[5],"ligand":[6,214],"gated":[7],"ion":[8],"channels":[9],"of":[10,24,47,117,134,160,172,188,204],"broad":[11],"distribution":[12],"and":[13,30,33,50,83,124,163,186,192,196,207],"structural":[14],"heterogeneity.":[15],"Their":[16],"functional":[17],"diversity":[18],"demonstrated":[19],"involvement":[20],"in":[21,37,44,73,101,194,197,212],"a":[22,45,75,91],"variety":[23],"neuronal":[25],"processes":[26],"(e.g.,":[27,151],"sensory":[28],"gating":[29],"cognitive":[31,119],"function)":[32],"generated":[34],"great":[35],"interest":[36],"them":[38],"as":[39,77,111],"targets":[40],"for":[41,114],"therapeutic":[42,81,141,170],"intervention":[43],"number":[46],"neuropathological":[48],"conditions":[49],"diseases.":[51],"In":[52,178],"order":[53],"to":[54,63,78,148],"control":[55],"distinct":[56,70],"functions":[58],"pharmacologically,":[59],"it":[60],"is":[61],"important":[62],"design":[64],"ligands":[65],"that":[66,129,174],"selectively":[67],"interact":[68],"with":[69],"receptor":[71],"subtypes":[72],"such":[74],"way":[76],"maximize":[79],"the":[80,85,96,115,130,135,169,184,189,201,209],"effect":[82],"minimize":[84],"adverse":[86],"effects.":[87],"The":[88],"alpha7":[89,105,136,176,190,213],"nAChR,":[90],"CNS":[92],"subtype,":[93],"has":[94],"been":[95,109,146],"most":[97],"intensively":[98],"studied":[99],"nAChR":[100,106,137,191],"recent":[102],"years.":[103],"Selective":[104],"agonists":[107],"have":[108,144],"developed":[110],"potential":[112,171],"candidates":[113],"treatment":[116],"schizophrenia,":[118],"disorders":[120],"(including":[121],"Alzheimer's":[122],"disease),":[123],"inflammation.":[125],"Despite":[126],"early":[127],"concerns":[128],"rapid":[131],"desensitization":[132],"property":[133],"would":[138],"limit":[139],"their":[140],"potential,":[142],"several":[143],"already":[145],"advanced":[147],"clinical":[149,202],"trials":[150],"PH-399733,":[152],"Pfizer;":[153],"MEM":[154],"3454,":[155],"Memory":[156],"Pharmaceuticals/Roche).":[157],"Further":[158],"development":[159],"allosteric":[161],"modulators":[162],"pharmaceutically":[164],"relevant":[165],"antagonists":[166],"might":[167],"expand":[168],"compounds":[173],"target":[175],"nAChRs.":[177],"this":[179],"review":[180,208],"we":[181],"briefly":[182],"describe":[183],"structure":[185],"function":[187],"its":[193],"vitro":[195],"vivo":[198],"pharmacology,":[199],"discuss":[200],"relevance":[203],"these":[205],"efforts,":[206],"current":[210],"progress":[211],"development.":[215]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1964072039","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
